生物
转录组
CD8型
T细胞受体
T细胞
细胞毒性T细胞
癌症研究
肝细胞癌
免疫系统
免疫学
肝癌
基因
计算生物学
基因表达
体外
遗传学
作者
Chunhong Zheng,Liangtao Zheng,Jae‐Kwang Yoo,Huahu Guo,Yuanyuan Zhang,Xinyi Guo,Boxi Kang,Ruozhen Hu,Julie Y. Huang,Qiming Zhang,Zhouzerui Liu,Ming-Hui Dong,Xueda Hu,Wenjun Ouyang,Jirun Peng,Zemin Zhang
出处
期刊:Cell
[Cell Press]
日期:2017-06-01
卷期号:169 (7): 1342-1356.e16
被引量:1847
标识
DOI:10.1016/j.cell.2017.05.035
摘要
Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherapies and the prediction of their clinical responses in cancers. Here, we perform deep single-cell RNA sequencing on 5,063 single T cells isolated from peripheral blood, tumor, and adjacent normal tissues from six hepatocellular carcinoma patients. The transcriptional profiles of these individual cells, coupled with assembled T cell receptor (TCR) sequences, enable us to identify 11 T cell subsets based on their molecular and functional properties and delineate their developmental trajectory. Specific subsets such as exhausted CD8+ T cells and Tregs are preferentially enriched and potentially clonally expanded in hepatocellular carcinoma (HCC), and we identified signature genes for each subset. One of the genes, layilin, is upregulated on activated CD8+ T cells and Tregs and represses the CD8+ T cell functions in vitro. This compendium of transcriptome data provides valuable insights and a rich resource for understanding the immune landscape in cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI